524 related articles for article (PubMed ID: 29519249)
1. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.
Glintborg D; Rubin KH; Nybo M; Abrahamsen B; Andersen M
Cardiovasc Diabetol; 2018 Mar; 17(1):37. PubMed ID: 29519249
[TBL] [Abstract][Full Text] [Related]
2. Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome.
Glintborg D; Hass Rubin K; Nybo M; Abrahamsen B; Andersen M
Eur J Endocrinol; 2015 May; 172(5):627-38. PubMed ID: 25656495
[TBL] [Abstract][Full Text] [Related]
3. Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome.
Rubin KH; Glintborg D; Nybo M; Abrahamsen B; Andersen M
J Clin Endocrinol Metab; 2017 Oct; 102(10):3848-3857. PubMed ID: 28938447
[TBL] [Abstract][Full Text] [Related]
4. Socioeconomic status in Danish women with polycystic ovary syndrome: A register-based cohort study.
Rubin KH; Andersen MS; Abrahamsen B; Glintborg D
Acta Obstet Gynecol Scand; 2019 Apr; 98(4):440-450. PubMed ID: 30516823
[TBL] [Abstract][Full Text] [Related]
5. Fracture Risk Is Decreased in Women With Polycystic Ovary Syndrome: A Register-Based and Population-Based Cohort Study.
Rubin KH; Glintborg D; Nybo M; Andersen M; Abrahamsen B
J Bone Miner Res; 2016 Apr; 31(4):709-17. PubMed ID: 26542642
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population.
Sirmans SM; Parish RC; Blake S; Wang X
J Investig Med; 2014 Aug; 62(6):868-74. PubMed ID: 24844662
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study.
Glintborg D; Rubin KH; Nybo M; Abrahamsen B; Andersen M
Endocr Connect; 2019 Oct; 8(10):1405-1415. PubMed ID: 31518989
[TBL] [Abstract][Full Text] [Related]
8. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study.
Behboudi-Gandevani S; Ramezani Tehrani F; Hosseinpanah F; Khalili D; Cheraghi L; Kazemijaliseh H; Azizi F
Fertil Steril; 2018 Dec; 110(7):1377-1386. PubMed ID: 30503137
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease risk in first-degree relatives of women with polycystic ovary syndrome.
Vipin VP; Dabadghao P; Shukla M; Kapoor A; Raghuvanshi AS; Ramesh V
Fertil Steril; 2016 May; 105(5):1338-1344.e3. PubMed ID: 26852421
[TBL] [Abstract][Full Text] [Related]
10. Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome.
Persson S; Elenis E; Turkmen S; Kramer MS; Yong EL; Poromaa IS
Fertil Steril; 2021 Sep; 116(3):862-871. PubMed ID: 34053678
[TBL] [Abstract][Full Text] [Related]
11. Diabetes Mellitus Mediates Risk of Depression in Danish Women with Polycystic Ovary Syndrome-A National Cohort Study.
Glintborg D; Petersen TG; Rubin KH; Andersen MS
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289658
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?
Daan NM; Louwers YV; Koster MP; Eijkemans MJ; de Rijke YB; Lentjes EW; Fauser BC; Laven JS
Fertil Steril; 2014 Nov; 102(5):1444-1451.e3. PubMed ID: 25239303
[TBL] [Abstract][Full Text] [Related]
13. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome.
Meun C; Gunning MN; Louwers YV; Peters H; Roos-Hesselink J; Roeters van Lennep J; Rueda Ochoa OL; Appelman Y; Lambalk N; Boersma E; Kavousi M; Fauser BC; Laven JS;
Clin Endocrinol (Oxf); 2020 Feb; 92(2):150-158. PubMed ID: 31638273
[TBL] [Abstract][Full Text] [Related]
14. Hypertension in Reproductive-Aged Women With Polycystic Ovary Syndrome and Association With Obesity.
Joham AE; Boyle JA; Zoungas S; Teede HJ
Am J Hypertens; 2015 Jul; 28(7):847-51. PubMed ID: 25542625
[TBL] [Abstract][Full Text] [Related]
15. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome.
Lo JC; Feigenbaum SL; Yang J; Pressman AR; Selby JV; Go AS
J Clin Endocrinol Metab; 2006 Apr; 91(4):1357-63. PubMed ID: 16434451
[TBL] [Abstract][Full Text] [Related]
17. Birth weight and polycystic ovary syndrome in adult life: a register-based study on 523,757 Danish women born 1973-1991.
Mumm H; Kamper-Jørgensen M; Nybo Andersen AM; Glintborg D; Andersen M
Fertil Steril; 2013 Mar; 99(3):777-82. PubMed ID: 23200688
[TBL] [Abstract][Full Text] [Related]
18. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
Meyer C; McGrath BP; Teede HJ
J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
[TBL] [Abstract][Full Text] [Related]
19. Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population-based cohort study.
Altinok ML; Glintborg D; Depont Christensen R; Hallas J; Andersen M
Clin Endocrinol (Oxf); 2014 Jun; 80(6):884-9. PubMed ID: 24224860
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study.
Schmidt J; Landin-Wilhelmsen K; Brännström M; Dahlgren E
J Clin Endocrinol Metab; 2011 Dec; 96(12):3794-803. PubMed ID: 21956415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
